Stockscreener 앱 받기
5.63
2.60%
-0.15
시장 영업 전:
5.73
0.10
+1.78%
4 D Molecular Therapeutics Inc 주식(FDMT)의 최신 뉴스
4D Molecular Therapeutics Inc. stock prediction for this weekShort-Term Stock Trend Forecast Guide - Newser
Why 4D Molecular Therapeutics Inc. stock attracts strong analyst attentionMulti-Bagger Detection with Trend Tools - Newser
Volatility clustering patterns for 4D Molecular Therapeutics Inc.Price Forecast Based on AI Analysis - Newser
What makes 4D Molecular Therapeutics Inc. stock price move sharplyDividend Strategy Summary With 10-Year Outlook - Newser
How to build a custom watchlist for 4D Molecular Therapeutics Inc.Free Price Action Based Buy Opportunity List - Newser
Developing predictive dashboards with 4D Molecular Therapeutics Inc. dataShort-Term Sector Movement Forecast Generator - Newser
How 4D Molecular Therapeutics Inc. stock performs during market volatilityReal Time Growth Signal with Smart Setup - Newser
What technical models suggest about 4D Molecular Therapeutics Inc.’s comebackConsistent Gain Plan with AI Support - Newser
Technical analysis overview for 4D Molecular Therapeutics Inc. stockFree Portfolio Diversification Stock Ideas - Newser
Using AI based signals to follow 4D Molecular Therapeutics Inc.Long-Term Safety Investment Analysis Report - Newser
Heatmap analysis for 4D Molecular Therapeutics Inc. and competitorsFree Momentum Based Equity Trading Plan - Newser
Is 4D Molecular Therapeutics Inc. forming a reversal patternAI-Based Reversal Point Prediction Signal - Newser
Can you recover from losses in 4D Molecular Therapeutics Inc.Daily Profit Watch With Forecast Confidence - Newser
Can trapped investors hope for a rebound in 4D Molecular Therapeutics Inc.AI Enhanced Strategy for Portfolio Growth - Newser
Will 4D Molecular Therapeutics Inc. price bounce be sustainableReal-Time Entry Signals for Top Stocks - Newser
Will earnings trigger a reversal in 4D Molecular Therapeutics Inc.Volume Spike Detection for Early Breakouts - Newser
What makes 4D Molecular Therapeutics Inc. stock attractive to long term investorsFree Real Market Momentum Signal Generator - Newser
4D Molecular Therapeutics to Participate in H.C. Wainwright Ophthalmology Virtual Conference - AInvest
4D Molecular Therapeutics shares fall 1.92% premarket ahead of H.C. Wainwright 5th Annual Ophthalmology Virtual Conference. - AInvest
4D Molecular Therapeutics (FDMT) to Release Earnings on Thursday - Defense World
4D Molecular Therapeutics shares fall 2.73% intraday after announcing participation in H.C. Wainwright 5th Annual Ophthalmology Virtual Conference. - AInvest
Using fundamentals and technicals on 4D Molecular Therapeutics Inc.AI Volatility Forecast and Risk Monitor - Newser
4D Molecular Therapeutics Inc expected to post a loss of 88 cents a shareEarnings Preview - TradingView
Fibonacci Support Holding Strong in 4D Molecular Therapeutics Inc.Conservative Long Term Growth Plans Under Review - beatles.ru
Why is 4D Molecular Therapeutics Inc. stock attracting strong analyst attentionAchieve consistent profits with proven methods - Jammu Links News
4D Molecular Therapeutics’ (FDMT) Buy Rating Reiterated at Chardan Capital - Defense World
Is 4D Molecular Therapeutics Inc. a growth stock or a value stockProven strategies for superior portfolio growth - Jammu Links News
What is the dividend policy of 4D Molecular Therapeutics Inc. stockGet daily expert analysis on top stocks - Jammu Links News
Is 4D Molecular Therapeutics Inc. Stock a Good Fit for Conservative InvestorsFree Capital Preserving Trade Plan Templates - Newser
What is the risk reward ratio of investing in 4D Molecular Therapeutics Inc. stockExplosive capital gains - Jammu Links News
What are 4D Molecular Therapeutics Inc. company’s key revenue driversCapitalize on fast-growing investment opportunities - Jammu Links News
Does 4D Molecular Therapeutics Inc. stock perform well during market downturnsRapid profit acceleration - Jammu Links News
Is 4D Molecular Therapeutics Inc. stock overvalued or undervaluedInvest smarter with data-backed trading alerts - Jammu Links News
What are the technical indicators suggesting about 4D Molecular Therapeutics Inc.Spectacular growth rates - Jammu Links News
When is 4D Molecular Therapeutics Inc. stock expected to show significant growthMassive stock growth - Jammu Links News
4D Molecular Therapeutics Showcases Positive Trial Results, Charts New Growth Trajectory - timothysykes.com
4D Molecular (FDMT) Stock Climbs Following Promising Retina Therapy Data - Stocks Telegraph
4D Molecular Therapeutics Rallies On Heels Of Diabetes-Related Vision Study - 富途牛牛
How volatile is 4D Molecular Therapeutics Inc. stock compared to the marketEntry Signal Forecasts With Low Risk - Jammu Links News
4D Molecular: Time to Buy After Recent Surge? - StocksToTrade
4D Molecular Therapeutics: A Market Shift? - timothysykes.com
4D Molecular Therapeutics shares rise 30.44% premarket after presenting positive 60-week results for 4D-150. - AInvest
Chardan Capital Maintains Buy on 4D Molecular, Raises PT to $25 - AInvest
4D Molecular Therapeutics stock soars after positive DME trial results By Investing.com - Investing.com Canada
Will a bounce in 4D Molecular Therapeutics Inc. offer an exitPrice Action Trading with Volume Confirmation - Newser
4D Molecular Therapeutics Shares Surge 50.89% on Positive Clinical Trial Results - AInvest
4D Molecular Therapeutics (FDMT) Shares Soar 37.78% on Positive Clinical Trial Results - AInvest
4D Molecular Therapeutics shares rise 56% premarket after presenting positive 60-week results for 4D-150. - AInvest
4D Molecular (FDMT) Shows Promising Results in Clinical Trial fo - GuruFocus
4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update - GlobeNewswire
Breakthrough: 4D-150 DME Treatment Shows 78% Reduction in Injections, FDA and EMA Clear Path to Approval - Stock Titan
How does 4D Molecular Therapeutics Inc. compare to its industry peersBeginner Investor Strategy With Proven Results - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):